Harmony Biosciences Holdings, Inc. ·
HRMY 8-K/A 2026-10-30
Harmony Biosciences Holdings, Inc. (HRMY) 8-K/A dated 2026-10-30 — accession 0001104659-26-120673. This URL is the filing, not the HRMY hub.
Harmony Biosciences Holdings, Inc. (HRMY) is a biotechnology company listed on NASDAQ.
Harmony Biosciences Holdings, Inc. filed a 8-K/A on 2026-10-30. Accession 0001104659-26-120673.
Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported HRMY revenue for 2025-12-31 was $868.5M. Net income was $158.7M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. HRMY currently screens at market cap $1.96B.
Not investment advice. The HRMY SEC hub lists recent forms. The stock page is the research view.